🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/03/2016 | 126,00 | 126,81 | 121,42 | 121,60 | -3,85% | 4,28% | 626.400 |
| 22/03/2016 | 124,76 | 127,38 | 124,24 | 126,47 | +1,47% | 2,52% | 656.500 |
| 21/03/2016 | 122,19 | 126,24 | 121,30 | 124,64 | +1,51% | 4,04% | 591.200 |
| 18/03/2016 | 117,71 | 123,40 | 116,50 | 122,78 | +4,03% | 5,86% | 960.000 |
| 17/03/2016 | 121,41 | 123,35 | 117,03 | 118,02 | -2,82% | 5,21% | 903.700 |
| 16/03/2016 | 121,22 | 124,85 | 119,61 | 121,44 | +0,98% | 4,32% | 725.400 |
| 15/03/2016 | 125,57 | 125,57 | 119,55 | 120,26 | -5,08% | 4,79% | 733.700 |
| 14/03/2016 | 125,08 | 128,71 | 125,00 | 126,69 | +1,64% | 2,97% | 850.700 |
| 11/03/2016 | 124,13 | 127,00 | 123,13 | 124,64 | +1,66% | 3,12% | 592.700 |
| 10/03/2016 | 125,22 | 127,85 | 121,92 | 122,61 | -1,10% | 4,74% | 519.400 |
| 09/03/2016 | 125,19 | 125,19 | 121,37 | 123,97 | -0,67% | 3,05% | 601.300 |
| 08/03/2016 | 131,38 | 133,69 | 124,50 | 124,80 | -5,36% | 6,99% | 608.200 |
| 07/03/2016 | 127,00 | 133,69 | 125,26 | 131,87 | +3,31% | 6,64% | 614.700 |
| 04/03/2016 | 126,00 | 129,72 | 124,10 | 127,64 | +1,30% | 4,46% | 658.800 |
| 03/03/2016 | 128,48 | 129,64 | 124,97 | 126,00 | -2,23% | 3,63% | 833.700 |
| 02/03/2016 | 126,94 | 129,04 | 125,74 | 128,88 | +1,85% | 2,60% | 647.800 |
| 01/03/2016 | 122,14 | 127,09 | 121,84 | 126,54 | +3,77% | 4,30% | 832.900 |
| 29/02/2016 | 123,01 | 127,31 | 121,54 | 121,94 | -1,50% | 4,69% | 895.200 |
| 26/02/2016 | 125,83 | 128,85 | 120,50 | 123,80 | -0,83% | 6,64% | 931.100 |
| 25/02/2016 | 128,75 | 129,00 | 119,05 | 124,83 | -3,36% | 7,73% | 903.500 |
| 24/02/2016 | 126,26 | 130,37 | 124,56 | 129,17 | +1,13% | 4,60% | 707.900 |
| 23/02/2016 | 128,20 | 130,82 | 127,48 | 127,73 | -0,31% | 2,61% | 488.100 |
| 22/02/2016 | 128,37 | 130,51 | 126,98 | 128,13 | +0,64% | 2,75% | 689.500 |
| 19/02/2016 | 128,49 | 128,67 | 123,50 | 127,32 | -0,45% | 4,02% | 1.056.000 |
| 18/02/2016 | 132,00 | 133,22 | 126,60 | 127,89 | -2,83% | 5,02% | 838.500 |
| 17/02/2016 | 130,45 | 133,84 | 129,01 | 131,62 | +1,38% | 3,70% | 526.600 |
| 16/02/2016 | 128,40 | 131,39 | 127,58 | 129,83 | +2,58% | 2,97% | 860.300 |
| 12/02/2016 | 124,18 | 128,20 | 121,71 | 126,56 | +4,07% | 5,23% | 731.600 |
| 11/02/2016 | 117,79 | 122,85 | 117,08 | 121,61 | +1,56% | 4,90% | 820.500 |
| 10/02/2016 | 120,83 | 126,08 | 119,59 | 119,74 | +0,35% | 5,37% | 706.700 |